73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
AngioDynamics Inc
Closed
SectorHealthcare
10.57 1.83
Overview
Share price change
24h
Min
10.27
Max
10.85
Income | 4.6M -6.4M |
|---|---|
Sales | 3.7M 79M |
Profit margin | -7.994 |
Employees | 675 |
EBITDA | 4.4M -436K |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +85.51% upside |
Next Earnings | 1 Apr 2026 |
|---|
Market Cap | -119M 426M |
|---|---|
Previous open | 8.74 |
Previous close | 10.57 |
News Sentiment
By Acuity
60%
40%
296 / 352 Healthcare
Technical Score
By Trading Central
Confidence
Bearish Evidence
AngioDynamics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
AngioDynamics Inc Forecast
Price Target
By TipRanks
85.51% upside
12 Months Forecast
Average 19.33 USD 85.51%
High 24 USD
Low 16 USD
Based on 3 Wall Street analysts offering 12 month price targets forAngioDynamics Inc - Dist in the last 3 months.
Sentiment
By Acuity
296 / 352 Healthcare
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About AngioDynamics Inc
AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.
Live chat